Generates First Half 2026 Revenue Growth of 60% Shoulder Innovations, Inc. (NYSE: SI), a cultivate(MD) portfolio company reported financial results for the first quarter ended June 30, 2026. Second Quarter Financial Highlights Recent Business Highlights “Our second quarter results build on a strong start to the year and reflect remarkable momentum across every dimension of […]
Experienced medical technology executive to accelerate commercialization, strategic partnerships, and market expansion following successful financing and strong company foundation. BINGHAM FARMS, MI – July 23, 2026 – SpinTech MRI, a leader in advanced quantitative magnetic resonance imaging (MRI) post-processing software, today announced the appointment of Brian Martin as Chief Executive Officer. Martin, an accomplished medical
Generates First Quarter Net Revenue Growth of 65% Year-Over-Year Shoulder Innovations, Inc. (NYSE: SI), a cultivate(MD) portfolio company reported financial results for the first quarter ended March 31, 2026. First Quarter Financial Highlights Recent Business Highlights “We are very pleased with our first quarter performance, which reflects accelerating revenue growth and intensifying commercial momentum across
The Focus Fund is cultivate(MD)’s fifth vehicle: a 2031-horizon strategy to identify, support, and exit best-in-class early-stage medical device companies. GRAND RAPIDS, Mich., May 11, 2026 — cultivate(MD), a leading medical device venture capital company, announced that its Focus Fund has deployed capital across four portfolio companies over the past month. THIS PRESS RELEASE IS
cultivate(MD) Focus Fund Announces Initial Capital Deployments Read More »
cultivate(MD) portfolio company Capitan Orthopedics, Inc. announced that it has been granted Breakthrough Device Designation from the U.S. Food & Drug Administration (FDA) for its SupraSpacer™ implant. “I am excited to announce that Capitan Orthopedics, Inc. has received Breakthrough Device Designation for its SupraSpacer™ implant technology. This is yet another milestone achievement for our team
cultivate(MD) portfolio company Shoulder Innovations, Inc., (NYSE: SI) announced full commercial launch of the InSet® I-135RFX Humeral Stem. The commencement of full launch follows a successful limited market release and receipt of additional FDA 510(k) clearance for an expanded set of fracture indications, enabling the InSet™ I-135RFX to now be utilized in all primary, revision,
